drugset / Trial / NCT01304589

Savella in Treatment for Provoked Vestibulodynia

NCT01304589

NaSingle-groupOpen-labelTreatment

Summary

The primary aim of this study is to determine the efficacy of milnacipran in reducing pain in women with provoked vestibulodynia (PVD), a centrally mediated pain syndrome similar to fibromyalgia, that is characterized by severe pain in the vestibule (outer vagina). The investigators will also determine whether associated symptoms in PVD, including psychological distress, impairment of sexual function, physical function, and quality of life, are correlated with a reduction in vulvar pain.

Timeline

Start
2010-10
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 200 mg

Indications